When considering if BPC-157 is too good to be true
Potential risks Serious risks and adverse events include: Allergic reaction to the medications or dye used in the injection Shoulder infection Depigmentation of the skin around the injection site (a whitening of the skin) Local fat atrophy around the injection site (thinning of the skin) Rupture of a tendon located in the path of the injection Nerve damage near the shoulder joint Bleeding at the injection site In addition to the above, corticosteroid injections increase the risk of: High blood pressure High blood sugar Decreased immune function Decrease in bone mineral density Bone infection (osteonecrosis) Reproductive hormone imbalance Metabolic changes (eg, increased appetite, weight gain, and fluid retention) These risks are typically associated with higher doses of corticosteroids, multiple injections, and for people with underlying medical conditions such as diabetes and heart problems

IGF-1 LR3 is used when researchers need to study IGF1R activation directly, bypassing the GH-IGF-1 axis entirely
The rapid attainment of peak plasma levels with parenteral administration makes this formulation particularly suitable for acute correction of deficiency states or for protocols requiring high systemic exposure
Together, BPC-157 and TB-500 improve motility, structural reorganization, growth factor expression, and cytoprotection